表皮NAD+枯竭驱动线粒体功能障碍,并导致肠道炎症
Elizabeth A Novak1,2, Erin C Crawford3, Heather L Mentrup1,2
1Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
在炎症性肠病 (IBD) 中降低的NAD+水平与PGC1α活性降低有关. 恢复NAD+水平可以改善结肠炎,但只有当PGC1α存在时,它才会改善结肠炎,这凸显了它在肠道健康中的关键作用.
科学领域:
- 线粒体生物学 线粒体生物学
- 胃肠病学 胃肠病学
- 分子医学是分子医学.
背景情况:
- 过氧酶增殖器激活的受体-联激活剂1-α (PGC1α) 的病理性下调有助于炎症性肠病 (IBD) 的病原发生.
- 在IBD中驱动PGC1α下调的确切机制尚不清楚.
研究的目的:
- 调查NAD+代谢在IBD期间PGC1α下调中的作用.
- 探索NAD+前体在实验性结肠炎中的治疗潜力.
主要方法:
- 在小鼠中诱导实验性结肠炎.
- 小鼠接受了尼古丁胺 рибоoside (NAD+前体) 的治疗.
- 测试包括西部污染,高分辨率呼吸计,NAD+量化和免疫沉.
主要成果:
- 在实验性大肠炎的小鼠和性大肠炎的人类的肠表皮中观察到显著的NAD+耗尽.
- 在实验性结肠炎中发现了增加的多ADP-ribose) 聚合酶-1 (PARP1) 活性,这是一个消耗NAD+的酶.
- NAD+前体治疗减少了结肠炎的严重程度,恢复了线粒体功能,并增加了活性PGC1α水平.
- 治疗效果取决于PGC1α的存在,因为缺乏PGC1α的转基因小鼠没有显示任何益处.
结论:
- PGC1α对于维护线粒体健康和肠表皮的恒常性至关重要.
- 通过PGC1α调节,NAD+代谢在IBD病原发生中发挥着关键作用.
- 像尼古丁胺核糖体这样的NAD+前体,代表了IBD的潜在治疗策略,取决于完整的PGC1α信号传递.
更多相关视频
07:32An Intravital Microscopy-Based Approach to Assess Intestinal Permeability and Epithelial Cell Shedding Performance
Published on: December 3, 2020
09:24Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
相关概念视频
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
